Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-023894
Filing Date
2025-11-17
Accepted
2025-11-17 16:36:00
Documents
78
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1539168
2 EX-10.3 ex10-3.htm EX-10.3 12200
3 EX-31.1 ex31-1.htm EX-31.1 18645
4 EX-31.2 ex31-2.htm EX-31.2 18604
5 EX-32.1 ex32-1.htm EX-32.1 7326
6 EX-32.2 ex32-2.htm EX-32.2 7252
7 GRAPHIC ex10-3_001.jpg GRAPHIC 16546
  Complete submission text file 0001493152-25-023894.txt   7501600

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE aimi-20250930.xsd EX-101.SCH 53722
9 XBRL CALCULATION FILE aimi-20250930_cal.xml EX-101.CAL 60037
10 XBRL DEFINITION FILE aimi-20250930_def.xml EX-101.DEF 241659
11 XBRL LABEL FILE aimi-20250930_lab.xml EX-101.LAB 408813
12 XBRL PRESENTATION FILE aimi-20250930_pre.xml EX-101.PRE 325936
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1295876
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 251491497
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)